Camargo Pharmaceutical Services has appointed Daniel S. Duffy as new chief executive officer. Kenneth V. Phelps, founder and president, will continue to be the visionary ambassador for the company, building the industry and driving new opportunities for Camargo.

Camargo helps global pharmaceutical companies identify, develop, and obtain numerous 505(b)(2) NDA approvals. 

“It has been an honor to lead this organization for 15 years and I am looking forward to expanding Camargo’s impact globally. I am happy Dan is joining us to expand the organization to support this vision,” said Phelps.

Dan brings over 20 years of experience in biopharma and strategic management consulting. Dan was most recently the vice president and general manager at McKesson Specialty Health. While there, he developed a differentiated specialty pharmacy model with Centers of Excellence around oncology, neurology and complex care, patient assistance and investigational product (clinical trials). 

“I am grateful for the vote of confidence and the opportunity to be part of the Camargo family. Camargo is filled with exceptionally smart and capable people who are passionate about improving medicines that serve our community,” said Duffy.